Gordon Crabtree, MD
Ophthalmology · Madison, WINPI 1548647696
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.6%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Regeneron at 49.9% of the total. Reporting peaked in 2024 at $5,575 and has fallen 94.8% since, to $292 in 2025. Among ophthalmology clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 42 payments — averaging $180.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$4K
- Apellis Pharmaceuticals, Inc.$2K
- Regeneron Healthcare Solutions, Inc.$810
- Genentech USA, Inc.$443
- Alimera Sciences, Inc.$179
- Astellas Pharma US Inc$176
- plus $269 from 4 others
What the payments were for
- Consulting fees$3,76450%
- Speaking & faculty fees$1,29817%
- Food & beverage$2,53233%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 4 | $3,789 |
| Apellis Pharmaceuticals, Inc. | 8 | $1,927 |
| Regeneron Healthcare Solutions, Inc. | 11 | $810 |
| Genentech USA, Inc. | 6 | $443 |
| Alimera Sciences, Inc. | 5 | $179 |
| Astellas Pharma US Inc | 3 | $176 |
| Alcon | 2 | $117 |
| Coopervision Inc. | 1 | $93 |
| Novartis | 1 | $38 |
| Eyepoint US, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,594 in reported general payments places this provider in the 90th percentile of 337 ophthalmology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 87 | $3,586 |
| Ketorolac Tromethamine | 32 | $553 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 25 | $185 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Madison
- Michael ShapiroMadison$71K
- Julia AgapovMadison$26K
- Neil FarbmanMadison$13K
- Eric WeinlanderMadison$9K
- Paul KaufmanMadison$6K
- Andrew ThliverisMadison$5K
- Shahed GhoghawalaMadison$4K
- Sina Rashidi KikanlooMadison$4K
- Suzanne van LandinghamMadison$4K
- Roomasa ChannaMadison$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.